Please use this identifier to cite or link to this item:
Title: Metabolic syndrome in young adults with epilepsy
Authors: Nair, SS
Harikrishnan, S
Sarma, PS
Thomas, SV
Keywords: Neurosciences & Neurology
Issue Date: 2016
Citation: 37 ,;61-64
Abstract: Purpose: Persons with epilepsy have higher cardiovascular mortality and morbidity compared to general population and alteration of their biochemical milieu is one of the proposed mechanisms. We aimed to study the prevalence of metabolic syndrome and cardiovascular risk factors in young adults with epilepsy and the association with antiepileptic drug use. Method: An observational study was conducted in persons with epilepsy aged 20-49 years using antiepileptic drugs regularly for the previous three years. The subjects were examined and their blood samples were collected for fasting blood glucose and lipid profile. Results: Over 18 months, 183 patients (120 males; 63 females) were recruited (mean age 32.5 +/- 8.9 years). Metabolic syndrome (MetS) by ATP III criteria was present in 54 (29.5%) subjects. People with MetS in our group had higher frequency of abdominal obesity (50.0%) and hypertriglyceridemia (55.5%) than diabetes/impaired fasting glucose (27.8%). Older age (p = 0.005) and use of valproate (p = 0.012) were associated with significant risk of MetS. Conclusion: Clinicians need to be vigilant regarding the risk of MetS while initiating treatment and following up persons with epilepsy. (C) 2016 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
URI: 10.1016/j.seizure.2016.03.002
Appears in Collections:Journal Articles

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.